Menu Search
Equities

Geratherm Medical AG

GME:HAM

Geratherm Medical AG

Actions
  • Price (EUR)4.32
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-40.82%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Geratherm Medical AG is a Germany-based medical technology. The Company operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. The Healthcare Diagnostic segment provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. The Medical Warming Systems provides solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. The Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

  • Revenue in EUR (TTM)25.03m
  • Net income in EUR1.04m
  • Incorporated2000
  • Employees188.00
  • Location
    Geratherm Medical AGFahrenheitstrasse 1GESCHWENDA 99331GermanyDEU
  • Phone+49 9 716991380
  • Fax+49 9 716991382
  • Websitehttps://www.geratherm.de
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.